GDF11 and pulmonary arterial hypertension: Our findings have potential influence outside PAH which adds more evidence implicating that GDF11 and its downstream signaling molecule STAT3 may be a potential candidate for therapeutic intervention aimed at improving muscle mass and even exercise tolerance across a wide range of conditions.